Developing Story: Triple Negative MBC - Hard Truths, Real Hope with Dr Sarah Premji
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: Triple Negative MBC - Hard Truths, Real Hope with Dr Sarah Premji

Triple negative metastatic breast cancer has long been considered the hardest subtype to treat. That is changing and faster than most patients realize. Dr. Sarah Premji joins Victoria Goldberg to break down two landmark FDA approvals, the science behind antibody-drug conjugates, and what's coming next in the pipeline

Read More